Evidence map›Paper›PMID 29437627›Full record

ArticleAntimicrobial agents and chemotherapy2018

Drug Susceptibility Profiling and Genetic Determinants of Drug Resistance in Mycobacterium kansasii.

Zofia Bakuła, Magdalena Modrzejewska, Lian Pennings, Małgorzata Proboszcz, Aleksandra Safianowska, Jacek Bielecki, Jakko van Ingen, Tomasz Jagielski

Open access · bronzeAbstract read
In one paragraph

Article in Antimicrobial agents and chemotherapy, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed, 2 pooled it
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 2 syntheses or guidelines pooled it, 45 citations in OpenAlex.

  1. Treatment of Nontuberculous Mycobacterial Pulmonary Disease: An Official ATS/ERS/ESCMID/IDSA Clinical Practice Guideline.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2020
    Guideline
  2. Guideline
  3. Article
  4. Article
  5. An enoyl-ACP reductase inhibitor, NITD-916, expresses anti-Antimicrobial agents and chemotherapy · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Molecular Characterisation ofPathogens (Basel, Switzerland) · 2023
    Article
  10. Article
  11. Review
  12. Article
  13. Review
  14. Article
  15. Determination of Clinical Characteristics ofAnnals of laboratory medicine · 2021
    Article
  16. Article
  17. A case of multidrug-resistantRespirology case reports · 2021
    Article
  18. A Murine Model ofFrontiers in microbiology · 2021
    Article
  19. Ethambutol-resistantJournal of clinical tuberculosis and other mycobacterial diseases · 2020
    Article
  20. Genomic Insights Into theFrontiers in microbiology · 2019
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 2 countries.

Zofia BakułaDepartment of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Magdalena ModrzejewskaDepartment of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Lian PenningsDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0003-3343-6823
Małgorzata ProboszczDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland.
Aleksandra SafianowskaDepartment of Internal Medicine, Pulmonary Diseases and Allergy, Medical University of Warsaw, Warsaw, Poland.
Jacek BieleckiDepartment of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland.
Jakko van IngenDepartment of Medical Microbiology, Radboud University Medical Center, Nijmegen, The Netherlands.ORCID 0000-0002-0581-2003
Tomasz JagielskiDepartment of Applied Microbiology, Institute of Microbiology, Faculty of Biology, University of Warsaw, Warsaw, Poland t.jagielski@biol.uw.edu.pl.
University of Warsaw · PLMedical University of Warsaw · PLRadboud University Nijmegen · NL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Very few studies have examined drug susceptibility of

Indexed as

AmikacinAntitubercular AgentsCiprofloxacinDrug Resistance, Multiple, BacterialEthambutolEthionamideKanamycinMicrobial Sensitivity TestsMycobacterium kansasiiMycobacterium tuberculosisRifabutinRifampinStreptomycinTuberculosis, Multidrug-ResistantAmikacinAntitubercular AgentsCiprofloxacinEthambutolEthionamideKanamycinRifabutinRifampinStreptomycindrug resistancemolecular resistanceMycobacterium kansasiisusceptibility testing

Identifiers

PMID29437627
PMCPMC5913922
OpenAlexW2789681693

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.